Riskpilot← Back to searchSign inGet full accessEpisurf Medical AB
ABActiveOrg 5567670541Karlavägen 60Engineering activities and related technical consultancy · NACE 7112Est. 200810-19 employees
Revenue 2024
SEK 1M
0% vs 2023
EBITDA margin
-5000.0%
0% vs 2023
Equity ratio
94.7%
Financial strength
Net profit 2024
SEK -202M
-53% vs 2023
| Revenue | SEK 1M | +0% |
| EBITDA | SEK -50M | +0% |
| Net profit | SEK -202M | -53% |
| Total assets | SEK 152M | -48% |
| Equity | SEK 144M | -47% |
| Employees | — | — |
Legal name
Episurf Medical AB
Org number
5567670541
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
6 oktober 2008
Share capital
SEK 7 000 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva forskning, utveckling och kommersialisering av material för medicintekniska ändamål och därmed förenlig verksamhet samt att direkt eller indirekt genom dotterbolag äga, utveckla och förvalta samt köpa och sälja fast egendom och därmed förenlig verksamhet.
Address
Karlavägen 60
Phone
+4686120020
Email
info@episurf.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 000 | 1 000 | 1 000 | 1 000 | 1 000 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −34 000 | −37 000 | −40 000 | −50 000 | −50 000 |
| Depreciation & amort. | −3 000 | −2 000 | −2 000 | −3 000 | −3 000 |
| EBIT | −37 000 | −39 000 | −42 000 | −53 000 | −53 000 |
| Net financials | — | — | — | −79 000 | −149 000 |
| Profit before tax | −37 000 | −39 000 | −42 000 | −132 000 | −202 000 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −37 000 | −39 000 | −42 000 | −132 000 | −202 000 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 340 000 | 453 000 | 439 000 | 290 000 | 152 000 |
| Equity | 332 000 | 446 000 | 403 000 | 271 000 | 144 000 |
| Long-term debt | 0 | 0 | 27 000 | 9 000 | 1 000 |
| Short-term debt | 8 000 | 9 000 | 9 000 | 10 000 | 8 000 |
| Total debt | 8 000 | 9 000 | 36 000 | 19 000 | 9 000 |
EBITDA margin
-5000.0%
This company
15.8%
Market median
-31746% vs market
20202024
Equity ratio
94.7%
This company
38.2%
Market median
+148% vs market
20202024
Return on equity
-140.3%
This company
18.4%
Market median
-863% vs market
20202024
Net profit margin
-20200.0%
This company
8.1%
Market median
-249483% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
DT Chief Auditor | Chief Auditor | 2020 |
EK Chief Executive Officer | Chief Executive Officer | 2026 |
JR Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (1) | ||
PH Chief Executive Officer | Chief Executive Officer | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2026 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Former (4) | ||
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 2020 – 2026 | |
| Board of Directors | 2020 – 2025 | |
| Board of Directors | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Episurf Medical AB (this company)
EPISURF DE GMBHEpisurf Australia Pty LtdEpisurf India Private LimitedEpisurf De GmbhEpisurf Medical IncEPISURF AUSTRALIA PTY LTDEPISURF INDIA PRIVATE LIMITEDEPISURF MEDICAL INCBoard members of Episurf Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Tobias Holmer Stråle | Chief Auditor | 0 companies |
| Eva Katarina Flodström | Chief Executive Officer | 0 companies |
| Jens Robert Andersson | Chief Executive Officer | 0 companies |
| Pål Harald Gustaf Ryfors | Chief Executive Officer | 0 companies |
| Jess Hanley Lonner | Board of Directors | 0 companies |
| Carl Christian Victor Krüeger | Board of Directors | 0 companies |
| Lars Birger Lönnquist | Board of Directors | 0 companies |
| Ulf Arne Grunander | Chairman | 0 companies |
| Annette Maria Rampe | Board of Directors | 0 companies |
| Leif Erik Sigfrid Ryd | Board of Directors | 0 companies |
| Laura Funk Shunk | Board of Directors | 0 companies |